NVO

Meet the Next Trillion-Dollar Companies: Our Top 7 Picks

These future trillion-dollar stocks are on their way to mythic valuation, supported by strong underlying fundamentals and prospects.

7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution

Obesity drug sales boomed in 2023 and will continue in 2024 making these weight loss stocks attratcive considerations for pharma investors.

Eli Lilly, Novo Nordisk Could Be First Trillion-Dollar Drug Stocks

Thanks to weight loss and obesity drugs, Eli Lilly and Novo Nordisk could become the first trillion-dollar stocks in the pharma industry.

NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?

The relaunch of Wegovy last year caused a mad dash by weight loss stocks to compete for market leadership in anti-obesity drugs.

Catalent (CTLT) Stock Pops 10% on Sale to Novo Nordisk

Catalent stock is rising higher on Monday after the company announced a $16.5 billion cash acquisition deal for CTLT shares.

The Road to a Trillion: 3 Stocks Next in Line for the Mega Milestone

Becoming a trillion-dollar milestone stock is more than just having a title. Rather, it indicates market dominance in the industry.

3 Phenomenal Stock-Split Stocks You Should Be Buying Now

Because the market sees stock splits as a sign of future growth these stock-split stocks could be tomorrow's winners.

Global Giants: 3 Multinational Corporations to Outperform in 2024

Participate in the growth of the global economy and consumption through these leading global stocks for 2024.

Why Is Omega Therapeutics (OMGA) Stock Up 111% Today?

Omega Therapeutics stock is rising higher on Thursday as investors in OMGA react to a search collaboration agreement with Novo Nordisk.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Pre-market stock movers are a hot topic this morning as we cover all of the biggest market news traders need to know about on Thursday!

7 Low-Volatility Stocks for Stable Growth in 2024

Wager on these stocks to buy for stable growth, handpicked for their low volatility and potential to weather economic headwinds.

The New Magnificent 7: 7 Stocks Rising to Prominence

The next magnificent 7 stocks continue to rise to prominence and offer strong returns to investors and are generally stable.

3 Biotech Stocks With Promising Pipelines and Big Growth Potential in 2024

These biotech stocks with promising pipelines are showing some major promise and growth potential for the new year.

7 Stocks Set to Capitalize on the Coming Year-End Rally

The stock market is poised to rally at the year end as multiple positive factors conspire to push certain sectors higher.

3 Consumer Goods Stocks That Will Define the Next Decade

These companies can be expected to continue shaping our lives for the foreseeable future thanks to their strong brands.

7 A-Rated Retirement Stocks for Your November Buy List

I know very few people who don’t look forward to retirement. Retirement means your life’s labor is done and you’ve achieved your financial goals. Whether…

The Magnificent Seven: 7 Stocks That Could Make It the ‘Elite Eight’

Investors curious to identify the next magnificent 7 stock should start here as the clues are fairly straightforward

7 Biotech Stocks to Buy for Big-Time Gains

Biotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research.

7 A-Rated Tech Stocks to Buy for November

By investing in tech stocks, investors can capitalize on groundbreaking technological advancements and be a part of the future.